The potential of carboxypeptidase M as a therapeutic target in cancer

By Denis Catherine J   Lambeir Anne-Marie  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 265-279

Informa Healthcare

Access to resources Recommend Favorite

Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer

By  

Current Medicinal Chemistry, Vol. 19, Iss. 6, 2012-02 ,pp. : 856-870

Bentham Science Publishers

Access to resources Recommend Favorite

Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation

By Estève M.-A.   Devictor-Pierre B.   Galy G.   André N.   Coze C.   Lacarelle B.   Bernard J.-L.   Monjanel-Mouterde S.  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 1, 2007-01 ,pp. : 39-42

Springer Publishing Company

Access to resources Recommend Favorite

Overcoming Treatment Resistance in HER2-Positive Breast Cancer: Potential Strategies

By Puglisi Fabio   >  

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1175-1193

Adis International

Access to resources Recommend Favorite

Potential use of exenatide for the treatment of obesity

By Folli Franco   Guardado Mendoza Rodolfo  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1717-1722

Informa Healthcare

Access to resources Recommend Favorite